DFTX 8-K 2026-09-08

Definium Therapeutics, Inc. (DFTX) 8-K dated 2026-09-08 — accession 0001193125-26-384403.

Definium Therapeutics, Inc. (DFTX) common stock.

Definium Therapeutics, Inc. filed a 8-K on 2026-09-08. Accession 0001193125-26-384403.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for DFTX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The DFTX SEC hub lists recent forms. The stock page is the research view.